[Effect of electroacupuncture on intestinal mucosal barrier in IBS-D rats via NGF/TrkA pathway mediated by mast cells].

Researchers investigated how electroacupuncture might help people with diarrhea-predominant irritable bowel syndrome (IBS-D), a condition causing frequent loose stools and abdominal discomfort. The study used rats with IBS-D symptoms and tested electroacupuncture at specific points (equivalent to ST25 and ST37 in humans) compared to medication and combination therapy. The scientists discovered that electroacupuncture works by calming overactive mast cells—immune cells that release inflammatory chemicals in the gut. When these cells become too active, they damage the intestinal lining, allowing harmful substances to leak into the bloodstream. Electroacupuncture reduced mast cell activation and decreased markers of intestinal barrier damage in the blood, including enzymes and bacterial toxins that shouldn't normally be present. The treatment also lowered levels of pain-related chemicals and improved the gut's protective lining. Rats receiving electroacupuncture showed less diarrhea, reduced abdominal pain sensitivity, and healthier intestinal tissue compared to untreated rats. The combination of electroacupuncture plus medication worked better than either treatment alone. The study found that electroacupuncture affects a specific cellular pathway (NGF/TrkA) that controls mast cell behavior and pain signaling. This research helps explain why acupuncture may relieve IBS-D symptoms—not just masking pain but actually healing the damaged intestinal barrier. While these results are promising, they come from animal studies, and human trials would be needed to confirm similar benefits in IBS-D patients. If you're considering acupuncture for IBS-D, consult a licensed acupuncturist with experience treating digestive conditions.

This animal study examined electroacupuncture's effect on intestinal barrier function in IBS-D rats via mast cell-mediated NGF/TrkA pathway modulation. Researchers used 56 successfully modeled rats (maternal separation plus acetic acid enema and chronic restraint stress) divided into model, ketotifen, EA, and combination groups (n=14 each). EA was applied at bilateral ST25 and ST37 with 2Hz/100Hz disperse-dense wave at 0.3mA for 7 consecutive days. Results showed EA significantly reduced mast cell degranulation, decreased serum levels of CGRP, DAO, D-LA, LPS, and FD4 mean fluorescence intensity (P<0.01), and downregulated NGF, TrkA, and TRPV1 expression in colonic tissue. EA outperformed ketotifen in reducing FD4 and NGF/TrkA/TRPV1 protein expression, while combination therapy produced superior outcomes across all parameters. Pearson correlation analysis confirmed positive correlation between CGRP levels and intestinal permeability markers (P<0.001). Clinical implications suggest electroacupuncture may restore intestinal barrier integrity in IBS-D through mast cell stabilization and neuroimmune pathway modulation, supporting its use as monotherapy or adjunctive treatment.